The combination therapy, referred to as DAGO+m, yielded a 91% overall response rate and a promising 2-year overall survival ...
Tatiana Schlossberg, President John F. Kennedy's granddaughter, has died. Here's what to know about acute myeloid leukemia ...
MedPage Today on MSN
JFK's Granddaughter Dies From AML; GI Cancers Expected to Double; Cancer Trials Axed
Tatiana Schlossberg, daughter of Caroline Kennedy and granddaughter of President John F. Kennedy, died from acute myeloid ...
Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...
US Weekly on MSN
Inside Tatiana Schlossberg’s Cancer Battle With Acute Myeloid Leukemia Before Her Death at Age 35
Tatiana Schlossberg opened up in a New Yorker essay about terminal acute myeloid leukemia and missing time with her children ...
Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.
The most-read coverage of the latest updates in acute myeloid leukemia (AML) for 2025 focused on the evolution of targeted therapies, the promise of off-the-shelf chimeric antigen receptor (CAR) ...
A novel combination of two cancer drugs has shown great potential as a future treatment for patients with acute myeloid leukaemia (AML), one of the most common types of blood cancers. A new study has ...
Researchers at Oregon Health and Science University (OHSU) have discovered a promising new drug combination that could ...
Acute myeloid leukemia (AML) is a cancer of the bone marrow and the blood that progresses rapidly without treatment. The National Cancer Institute estimates 20,800 new cases of AML will be diagnosed ...
The blood cancers acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) are extremely challenging to treat. While advances in immunotherapy have cured many patients with other blood cancers, ...
News-Medical.Net on MSN
Combination therapy offers hope for AML patients facing drug resistance
A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results